Related Experiment Videos
[Anticancer drug screening test for human osteosarcoma transplanted into nude mice]
1Department of Orthopaedic Surgery, Kyorin University School of Medicine, Tokyo, Japan.
Nihon Seikeigeka Gakkai Zasshi
|November 1, 1988
Summary
A novel toluidine-blue staining method effectively screens anticancer drug efficacy in osteosarcoma models. Cis-platinum demonstrated the highest effectiveness among tested drugs, validating the new method.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Context:
- Osteosarcoma is a challenging bone cancer requiring effective therapeutic strategies.
- Preclinical models are crucial for evaluating novel anticancer agents.
- Traditional methods for assessing drug efficacy can be time-consuming.
Purpose:
- To evaluate the efficacy of five anticancer drugs against osteosarcoma xenografts in nude mice.
- To introduce and validate a novel toluidine-blue staining method for assessing drug-induced tumor cell viability.
- To compare the efficacy of Cis-platinum, SF-1739HP, Melphalan, Peleomycin, and Aclacinomycin.
Summary:
- Osteosarcoma tissue was xenografted into nude mice, and various anticancer drugs were administered.
- Tumor growth was monitored, and a new method involving toluidine-blue staining of tumor cell suspensions was developed.
- The staining method classified tumor cells into strongly-positive, weakly-positive, and negative categories, correlating well with traditional tumor weight measurements.
- Cis-platinum exhibited the most significant anticancer effect, followed by SF-1739HP, Melphalan, Peleomycin, and Aclacinomycin.
Impact:
- The toluidine-blue staining method provides a simple and efficient approach for screening anticancer drug effectiveness.
- This method can accelerate the discovery and development of new osteosarcoma treatments.
- Findings confirm Cis-platinum's potent activity and rank other agents, aiding future therapeutic decisions.